The Mergers & Acquisitions Strategies in Pharmaceutical and Biotechnology Industries - A Case Study of Roche and Genentech
碩士 === 國立中山大學 === 國際高階經營管理碩士班 === 95 === Mergers and acquisitions (M&As) are one of the most important strategies for pharmaceutical and the biotechnology industry to gain access to valuable technological resources in recent years. The M&As activities and outcomes of famous pharmaceutical co...
Main Authors: | Li-ching Chang, 張立青 |
---|---|
Other Authors: | Chi-Cheng Wu |
Format: | Others |
Language: | zh-TW |
Published: |
2007
|
Online Access: | http://ndltd.ncl.edu.tw/handle/9w658j |
Similar Items
-
A Study on Mergers & Acquisitions and Competition Law Issues of Biotechnology and Pharmaceutical Industries
by: Kai-Chiang Tung, et al.
Published: (2018) -
The Mergers & Acquisitions Strategies in Biotechnology Industries: An Empirical Study
by: Sheng-hsiung Hsu, et al.
Published: (2003) -
Do Investors View Excess Capacity as a Determinant of Mergers and Acquisitions in the Pharmaceutical and Biotechnology Industry?
by: Volk, Jennifer M
Published: (2010) -
The Drivers of Mergers and Acquisitions in Pharmaceutical Industry
by: Ji, Fan
Published: (2012) -
Mergers and acquisitions in the pharmaceutical and biotech industries
by: Ireland, John M. (John Mathias), 1964-
Published: (2005)